TearLab Corporation TEAR
No live quote for TEAR yet.
- Market cap
- 2.81M
- Revenue (ttm)
- 27.36M
- EPS (ttm)
- -3.05
- Shares out
- 5.74M
- P/E ratio
- -0.16
- Forward P/E
- -0.24
- Volume
- 308.95K
- Avg volume
- 171.88K
- Open
- 0.51
- Previous close
- 0.6303
- Beta
- 1.90
- Analysts
- Hold
- Price target
- 5.50
Key statistics
- Enterprise value
- 0
- PEG ratio
- -0.01
- Price / sales
- 0.10
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -5.27M
- Total cash
- 7.71M
- Total debt
- 27.84M
- Return on equity
- 0.00%
- Short % of float
- 17.77%
- 50-day average
- 0.994286
- 200-day average
- 1.56
Analyst view
Consensus: hold
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.62.
Financials — quick view
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 2016 | Roth Capital | down | — | Neutral |
| Jul 11, 2016 | Rodman & Renshaw | init | — | Buy |
| May 4, 2016 | Feltl & Co. | up | — | Strong Buy |
| Mar 8, 2016 | Feltl & Co. | up | — | Strong Buy |
| Nov 5, 2014 | Feltl & Co. | up | — | Strong Buy |
| Aug 7, 2014 | Feltl & Co. | down | — | Buy |
About TearLab Corporation
TearLab Corporation operates as an in-vitro diagnostic company in the United States. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The companys system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical Laboratories & Research
- Country
- United States
- Website
- tearlab.com
News
Your note
Sign in to keep a note on TEAR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AWM INVESTMENT COMPANY, INC. | Beneficial Owner (10% or more) | Sale | Mar 29, 2017 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Altrinsic Global Advisors, LLC | 5.29% | 303,510 | 406.70K | Sep 29, 2017 |
| Perkins Capital Management, Inc. | 3.66% | 209,973 | 281.36K | Sep 29, 2017 |
| Vanguard Group, Inc. (The) | 0.90% | 51,802 | 69.41K | Sep 29, 2017 |
| Renaissance Technologies, LLC | 0.48% | 27,583 | 36.96K | Sep 29, 2017 |
| Geode Capital Management, LLC | 0.48% | 27,529 | 36.89K | Sep 29, 2017 |
| J. P. Marvel Investment Advisors, LLC | 0.31% | 17,541 | 23.50K | Sep 29, 2017 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.86% | 49,452 | 82.09K | Jun 29, 2017 |
| Fidelity Extended Market Index Fund | 0.43% | 24,963 | 65.65K | Jul 30, 2017 |
| Royce Micro Cap Trust | 0.15% | 8,500 | 14.11K | Jun 29, 2017 |
| Vanguard Total Stock Market Index Fund | 0.05% | 2,600 | 4.32K | Jun 29, 2017 |
| Fidelity Total Market Index Fund | 0.03% | 1,739 | 4.57K | Jul 30, 2017 |
| iShares Core S&P Total U.S. Stock Market ETF | 0.02% | 1,007 | 2.65K | Jul 30, 2017 |